Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Arch Therapeutics, Inc. (ARTH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-22Sep-30-21Sep-30-20Sep-30-19Sep-30-18Sep-30-17Sep-30-16Sep-30-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.00.00.00.00.0
            Revenue growth  35.3%       
Cost of goods sold  0.10.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.00.00.00.0
            Gross margin  -229.0%-127.3%      
Selling, general and administrative   [+]4.55.03.74.04.65.24.43.7
Research and development  1.21.41.62.42.92.11.71.8
EBITDA   [+]-5.7-6.4-5.3-6.4-7.4-7.3  
            EBITDA margin  -36452.9%-55119.2%      
Depreciation and amortization  0.00.00.00.00.00.0  
EBIT   [+]-5.7-6.4-5.4-6.4-7.4-7.3-6.1-5.5
            EBIT margin  -36473.3%-55141.6%      
Interest expense  0.60.20.0  0.10.30.4
Other income (expense), net   [+]1.00.30.71.82.6-0.40.32.9
Pre-tax income  -5.3-6.2-4.7-4.5-4.8-7.8-6.0-2.9
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -5.3-6.2-4.7-4.5-4.8-7.8-6.0-2.9
            Net margin  -33707.2%-53960.1%      
   
Basic EPS   [+]($0.02)($0.03)($0.02)($0.03)($0.03)($0.05)($0.05)($0.04)
Diluted EPS   [+]($0.02)($0.03)($0.02)($0.03)($0.03)($0.05)($0.05)($0.04)
   
Shares outstanding (basic)   [+]263.8208.0188.1166.3152.7142.7121.581.4
Shares outstanding (diluted)   [+]263.8208.0188.1166.3152.7142.7121.581.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy